Advances in FDG PET probes in surgical oncology.

Whole-body positron emission tomography (WB-PET) has been developed as a sensitive, cost-effective method for imaging malignant disease. WB-PET provides complete body imaging with a single scanning approach for a variety of malignancies. With increasing clinical experience, the indications for its use have broadened. This article reviews current uses of the technology and discusses some potential applications, particularly the utility of a commercially available surgical gamma probe for detecting the gamma particles emitted in the decay process of FDG.

[1]  R. Raylman.  Performance of a dual, solid-state intraoperative probe system with 18F, 99mTc, and (111)In. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  N. Petrelli,et al.  Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Morton,et al.  Surgical resection for melanoma metastatic to the gastrointestinal tract. , 1996, Archives of surgery.

[4]  D. Morton,et al.  Standardized probe-directed sentinel node dissection in melanoma. , 2000, Surgery.

[5]  M. Spieth,et al.  A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  J E Holden,et al.  Direct Measurement of the λ of the Lumped Constant of the Deoxyglucose Method in Rat Brain: Determination of λ and Lumped Constant from Tissue Glucose Concentration or Equilibrium Brain/Plasma Distribution Ratio for Methylglucose , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  E. Martin,et al.  Radioimmunoguided surgery for patients with liver metastases secondary to colorectal cancer , 1998, Annals of Surgical Oncology.

[8]  R L Wahl,et al.  Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  E. Martin,et al.  Radioimmunoguided surgery for colorectal cancer , 2006, Annals of Surgical Oncology.

[10]  Segall,et al.  9:45-10:00. Positron Emission Tomography (PET) is Superior to Computerized Tomography (CT) for Metastatic Staging in Melanoma Patients. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[11]  R L Wahl,et al.  Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. Beatty,et al.  Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer. , 1991, Archives of surgery.

[13]  R L Wahl,et al.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1991, Radiology.

[14]  P. V. van Diest,et al.  Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. , 1998, Journal of the American College of Surgeons.

[15]  G. Watkins,et al.  Detection of unsuspected metastasis in a melanoma patient with positron emission tomography. , 1995, Clinical nuclear medicine.

[16]  J. Pruim,et al.  PET with L-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  A. Buck,et al.  Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1995, Radiology.

[18]  R. Wahl,et al.  Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  H. Malamud.  Introductory Physics of Nuclear Medicine , 1977 .

[20]  A. Lammertsma,et al.  Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods , 2000, European Journal of Nuclear Medicine.

[21]  E. Martin,et al.  Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system). , 1989, Archives of surgery.

[22]  T. F. Barrett,et al.  Lung torsion after percutaneous needle biopsy of lung. , 1992, AJR. American journal of roentgenology.

[23]  E. Hoffman,et al.  Intraoperative beta probe: a device for detecting tissue labeled with positron or electron emitting isotopes during surgery. , 1994, Medical physics.

[24]  V. Gupta,et al.  99m-Technetium sestamibi localized solitary parathyroid adenoma as an indication for limited unilateral surgical exploration. , 1998, American journal of surgery.

[25]  R. Essner,et al.  Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. , 2001, The Journal of surgical research.

[26]  R. Wahl,et al.  18F‐2‐deoxy‐2‐fluoro‐D‐glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron‐emission tomography , 1991, Cancer.

[27]  N. Petrelli,et al.  Intraoperative determinants of unresectability for patients with colorectal hepatic metastases , 1998, Cancer.

[28]  Peter Schlag,et al.  Resection of the liver for colorectal carcinoma metastases , 1988, Diseases of the colon and rectum.

[29]  S S Gambhir,et al.  Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  D. Reintgen,et al.  Localization of malignant melanoma using monoclonal antibodies. , 1991, Archives of surgery.

[31]  L. Hann,et al.  Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. , 1998, Annals of surgery.

[32]  S. Packer.  Tumor detection with radiopharmaceuticals. , 1984, Seminars in nuclear medicine.

[33]  Q. Chu,et al.  Patient selection for hepatic resection of colorectal metastases. , 1996, Archives of surgery.

[34]  R. Essner,et al.  Accuracy of gamma probes in localizing radioactivity: in-vitro assessment and clinical implications. , 2000, Cancer biotherapy & radiopharmaceuticals.

[35]  K. Hughes.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. , 1988, Surgery.

[36]  P. Makler.  Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  F Rey,et al.  Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis , 1993, Cancer.

[38]  C. Lightdale,et al.  Endoscopic Ultrasonography in the Diagnosis, Staging and Follow-Up of Esophageal and Gastric Cancer , 1992, Endoscopy.

[39]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[40]  D K Owens,et al.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.

[41]  H. B. Barber,et al.  Lung cancer detection using a miniature sodium iodide detector and cobalt-57 bleomycin. , 1984, Chest.

[42]  F. Marincola,et al.  Selection factors resulting in improved survival after surgical resection of tumors metastatic to the lungs. , 1990, Archives of surgery.

[43]  K. Bland,et al.  Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. , 1991, Archives of surgery.